Enterprise record

Cocrystal Pharma, Inc.

Public governance Claims and source records for this enterprise.

Alpha ID: alpha:company:4e03da4f-3295-49c4-be52-3a6a12dcd44bVersion: public-1As of: unavailable

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Identity

unclaimed

Evidence

source reported

Evaluation

Unknown

Monitoring

Unknown

Authority

Unknown

Freshness

Observed 2026-09-27

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 28, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 27, 2026

    Supports 3 claims
    • Legal Name: Cocrystal Pharma, Inc. · Claim reviewed: Sep 27, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 27, 2026
    • Published Fact: US · Claim reviewed: Sep 27, 2026

  2. Cocrystal Pharma, Inc. DEF 14A 2025-05-05

    sec proxy · Source published: May 5, 2025 · Retrieved: Apr 28, 2026

    Supports 6 claims
    • Leadership Role: Anthony Japour: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Fred Hassan: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Phillip Frost: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Richard C. Pfenniger, Jr.: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Roger Kornberg: Director · Claim reviewed: Sep 27, 2026
    • Leadership Role: Steven Rubin: Director · Claim reviewed: Sep 27, 2026

  3. COCP 10-K executive officers

    sec filing · Source published: Mar 31, 2026 · Retrieved: May 16, 2026

    Supports 2 claims
    • Leadership Role: James J. Martin: Co-Chief Executive Officer, Chief Financial Officer · Claim reviewed: Sep 27, 2026
    • Leadership Role: Sam Lee: Co-Chief Executive Officer, President · Claim reviewed: Sep 27, 2026